New drug HS-10518 tested for safety in healthy women
Knowledge-focused
Completed
This early-stage study tested the safety and tolerability of a new drug called HS-10518 in 60 healthy women aged 18-40 in China. Participants received either the drug or a placebo, and researchers monitored for side effects and how the drug moved through the body. The goal was to…
Phase: PHASE1 • Sponsor: West China Second University Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC